Bourne Partners launches discussion on biosimilars via LinkedIn

Bourne Partners is pleased to announce that it is sponsoring a discussion group on LinkedIn, "Pharma and Healthcare M&A ".  The group is designed to be a networking and information hub for deal makers in the pharmaceutical and healthcare sectors.  In addition, we hope the site will serve as a reliable resource for regular and relevant market data and deal metrics.  The first topic of discussion asks, Which company, joint venture or collaboration is best positioned to cash-in on biosimilars? Visit the discussion group here:

Receive Your Report By Email